Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. - Wikidata - awgldk - TriplyDB

Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype.

Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype.

http://www.wikidata.org/entity/Q33573661

about

The endothelium abridges insulin resistance to premature aging SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 Epigenomics of leukemia: from mechanisms to therapeutic applications Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis Rapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cells The shape of the human language-ready brain Recapitulating physiological and pathological shear stress and oxygen to model vasculature in health and disease.Resveratrol and life extension.Epigenetic changes induced by curcumin and other natural compounds.Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells.SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.Pharmacologic Means of Extending Lifespan.Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia Resveratrol encapsulated in novel fusogenic liposomes activates Nrf2 and attenuates oxidative stress in cerebromicrovascular endothelial cells from aged rats.Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation.Blood flow modulation of vascular dynamics.Are sirtuins viable targets for improving healthspan and lifespan?Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-κB Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man Activation of Krüppel-Like Factor 2 with Ginkgo Biloba Extract Induces eNOS Expression and Increases NO Production in Cultured Human Umbilical Endothelial Cells.Pancreatic cancer chemoprevention by phytochemicals Ca2+/calmodulin-dependent protein kinase kinase β phosphorylation of Sirtuin 1 in endothelium is atheroprotective.Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium.Transcription factor Krüppel-like factor 2 plays a vital role in endothelial colony forming cells differentiation.Regulation of SIRT1 in cellular functions: role of polyphenols Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease.Resveratrol in cardiovascular disease: what is known from current research?Nitric oxide: orchestrator of endothelium-dependent responses.MicroRNA Regulation of SIRT1.Intimal hyperplasia: slow but deadly.Epigallocatechin-3-gallate regulates the expression of Kruppel-like factor 4 through myocyte enhancer factor 2A Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model Tannic acid as a plant-derived polyphenol exerts vasoprotection via enhancing KLF2 expression in endothelial cells.SIRT1 inhibition affects angiogenic properties of human MSCs Mitochondrial matrix Ca²⁺ accumulation regulates cytosolic NAD⁺/NADH metabolism, protein acetylation, and sirtuin expression.Autophagic adaptation is associated with exercise-induced fibre-type shifting in skeletal muscle.Kruppel-like factor 2 regulates endothelial barrier function.Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.Suberanilohydroxamic Acid as a Pharmacological Kruppel-Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis.

P2860

Q24605364-F2051B51-6B56-4B33-AFD1-6F40670B88B6 Q24633063-1C523F95-81AF-4FE8-BEE7-7D6B6DD5DC5C Q26823403-1CC596DD-C303-4E5E-B1C9-88B2A53BFBA4 Q26852339-70432CFD-BB1F-49E9-B933-01E21224830A Q28482627-14F2B70E-A14C-4365-9876-0310470A12C4 Q28660204-00D30F11-B368-4120-A34E-A76E07527F28 Q33600738-8456AFB4-9EE4-43AC-9FE9-AD160E7D1D54 Q34160523-F907FB53-AE09-4DBE-84D8-8DA2D7FD0EFF Q34180255-D4B3544A-2CFD-4EFE-9C34-774D40B1B9BE Q34193616-F6F10C49-EFAA-45E1-9683-79A3A58FED70 Q34272924-C57E7BD9-EBD1-48BC-B397-9E1D645DB258 Q34279875-EBD7987C-193C-462A-AF3D-BFF68F63CB6E Q34449372-E90FD1D9-CB43-465E-998B-3548D521828B Q35023264-C7CD566E-7ED8-4E36-AC60-55CA0309765E Q35152861-3A8957DD-1EA1-4560-A997-DC4BC0361EFC Q35163967-B8AD2ABC-CC18-432D-9EE4-9B4194087AC9 Q36224629-BBA62C59-8D7D-45D2-85BB-27BE845E159A Q36385747-B1B1BA8F-55D7-43B9-B852-9C8FC043BFA6 Q36452628-1DFA13A4-2374-4ABA-BB61-AEAE4EF25465 Q36562488-13973B6F-C4DD-4E47-BDB6-7C87903B98A5 Q36721407-E57B680F-DEC7-424C-A4DE-FFEC870207F9 Q36763100-D3C9A615-4694-48B1-8676-B234CA066F67 Q36967874-6046D5EC-D35E-4DCE-BE02-008E76725668 Q37231719-6878902C-1714-453F-8E14-9303A279AE05 Q37345066-14DAEE67-C754-4182-A107-93FDFCF037ED Q37745178-07F8C92E-7879-4152-9A2A-ED44F10767AF Q37831940-8B42406D-45F3-4264-B85B-E533F1815E4E Q37891880-BE424600-3EFF-4CE4-8B0A-DA5B852AFCC4 Q37927098-DB761EC0-2FEF-4D85-B4FE-987A2B27CDE3 Q38000257-B2020768-44DB-49E0-8198-521418452FDB Q38023144-FA65BD98-9248-4349-A92B-E1952C02F070 Q39120647-9791DCF1-4E6A-4BC6-9163-6177139230DE Q39694748-037ACD0F-70B2-45B5-83D6-6535346794C1 Q41158648-4E53B71C-EFD0-4D53-A681-550DBF6FE2AC Q41964604-A92D1B50-BB78-41EE-9784-C3F4060CA50F Q42038471-C7A514ED-D2A8-409C-897F-DD8ED747B29D Q42475257-2222D2F8-9EB4-4B04-AF82-8A67DA46C147 Q42734905-5A82DF56-4167-402E-A255-94369571AB25 Q46517321-E9E0CACD-8BAC-4EC1-B087-ED2ACE8C76FE Q47345095-33AAA78B-DB46-48FE-8EF1-E59A589F6D5F

P2860

Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype.

http://www.wikidata.org/entity/Q33573661

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@ast

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@en

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@nl

type

label

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@ast

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@en

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@nl

prefLabel

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@ast

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@en

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@nl

P1433

Q33573661-ADCC6796-A3D6-4416-83BD-B235E47C452D

P1476

Q33573661-37BE6E67-C5F5-4D65-B7C7-4829272B8A4C

P2093

Q33573661-02FD2934-B7A8-444F-B94F-2C43CE69E05B

Q33573661-2705A74B-002C-4439-A385-DFBB917EF8DC

Q33573661-3DDB12E4-9340-413D-835D-B1811DAC46CE

Q33573661-43EDDE7A-CD65-4C95-AFC7-C6CE8633F15B

P2860

Q33573661-048069B0-8AAB-49A9-9489-497E3EBE5C21

Q33573661-0AC45DF8-70AF-478E-8F6F-2F72A03F0D6B

Q33573661-19A340E8-C787-49F7-A99F-032A9FE4A882

Q33573661-1BED3FB3-BA60-4FB5-A73C-9B174180E9A6

Q33573661-272584DB-498E-4349-BB74-219FB783404D

Q33573661-3FD5AB28-F6D0-43D8-9C5C-8AE574891BCB

Q33573661-5E4AD2AD-6268-41B2-A955-00F7445D0CCB

Q33573661-61B1075C-BF51-4DDB-9D6F-55D636A824F3

Q33573661-656EF92C-305A-4291-A18E-CF7CEC2FB04F

Q33573661-7B0A6DA5-30C7-4EAA-9524-5FB565FEAB5D

P304

Q33573661-1D7C9EC1-5AEB-403F-A456-FBA64B12990E

P31

Q33573661-CE7F2F57-22B5-4BD2-AEA4-83E5B0B00B60

P356

Q33573661-7765CF64-236F-46E4-9D3E-B7E6314E9228

P433

Q33573661-DFFD662F-F7CA-489D-9859-D9E29B4C98CE

P478

Q33573661-8E1B725B-0C2E-4571-A793-02656252E125

P577

Q33573661-21B13CF8-278E-4F71-849A-B172E7E970F3

P5875

Q33573661-F4D5B8AD-3D33-4CB0-AC68-891CFBE907B1

P698

Q33573661-DB330405-C716-4BD2-87C2-FFE616936DEC

P921

Q33573661-BFCAD9B1-BD68-4792-A4DB-7F8C53E943B2

P932

Q33573661-E267507C-FD49-4871-AED6-25935CB05224

P356

P1433

Cardiovascular Research

P1476

Activation of SIRT1 by resvera ...... lial vasoprotective phenotype.

@en

P2093

Guadalupe Villarreal

http://www.w3.org/2001/XMLSchema#string

Guillermo García-Cardeña

http://www.w3.org/2001/XMLSchema#string

Jorge Gracia-Sancho

http://www.w3.org/2001/XMLSchema#string

Yuzhi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

Therapeutic potential of resveratrol: the in vivo evidence

Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction

Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.

Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes

SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase

KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.

P304

514-519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVP337

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26881543

http://www.w3.org/2001/XMLSchema#string

P698

19815564

http://www.w3.org/2001/XMLSchema#string

P921

P932

2802207

http://www.w3.org/2001/XMLSchema#string